Literature DB >> 16135393

Live, attenuated Salmonella typhimurium vectoring Campylobacter antigens.

Donata R Sizemore1, Beth Warner, Julie Lawrence, Amy Jones, Kevin P Killeen.   

Abstract

We describe the evaluation of three live, attenuated deltaphoP/Q Salmonella enteric serovar Typhimurium strains expressing PEB1 minus its signal sequence (PEB1-ss) from three different plasmids: a pBR-based asd plasmid, an arabinose-based runaway plasmid, which each expressed PEB1-ss in the bacterial cytosol, and a PEB1::HlyA fusion plasmid that directs secretion of PEB1-ss into the extracellular milieu. Serum IgG responses specific for PEB1-ss were induced by pBR-derived and runaway plasmids, with 100 and 90% seroconversion, respectively, at a 1:500 dilution of anti-sera as measured by Western blot analysis, while the PEB1-ss::HlyA fusion plasmid induced serum IgG in only 20% of the mice. Although significant levels of anti-PEB serum IgG were induced, no protection against oral Campylobacter jejuni challenge was observed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135393     DOI: 10.1016/j.vaccine.2005.07.026

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Evaluation of Salmonella-vectored Campylobacter peptide epitopes for reduction of Campylobacter jejuni in broiler chickens.

Authors:  S L Layton; M J Morgan; K Cole; Y M Kwon; D J Donoghue; B M Hargis; N R Pumford
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

2.  Immunogenicity and immunoprotection of recombinant PEB1 in Campylobacter-jejuni-infected mice.

Authors:  Lian-Feng Du; Zhen-Jiang Li; Xian-Ying Tang; Jun-Qiong Huang; Wan-Bang Sun
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

Review 3.  Host-pathogen interactions in Campylobacter infections: the host perspective.

Authors:  Riny Janssen; Karen A Krogfelt; Shaun A Cawthraw; Wilfrid van Pelt; Jaap A Wagenaar; Robert J Owen
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

4.  Immunogenicity and protective efficacy of recombinant Campylobacter jejuni flagellum-secreted proteins in mice.

Authors:  Shahida Baqar; Lisa A Applebee; Theron C Gilliland; Lanfong H Lee; Chad K Porter; Patricia Guerry
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

5.  Evaluation of procedures for outer membrane isolation from Campylobacter jejuni.

Authors:  Rhonda I Hobb; Joshua A Fields; Christopher M Burns; Stuart A Thompson
Journal:  Microbiology (Reading)       Date:  2009-03       Impact factor: 2.777

6.  Recombinant PorA, the major outer membrane protein of Campylobacter jejuni, provides heterologous protection in an adult mouse intestinal colonization model.

Authors:  Anjum Islam; Raj Raghupathy; M John Albert
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

7.  Oral immunization with cholera toxin provides protection against Campylobacter jejuni in an adult mouse intestinal colonization model.

Authors:  M John Albert; Abu Salim Mustafa; Anjum Islam; Shilpa Haridas
Journal:  mBio       Date:  2013-05-07       Impact factor: 7.867

Review 8.  Advances in Campylobacter biology and implications for biotechnological applications.

Authors:  Byeonghwa Jeon; Wayne T Muraoka; Qijing Zhang
Journal:  Microb Biotechnol       Date:  2009-05-19       Impact factor: 5.813

9.  Evaluations of Alkyl hydroperoxide reductase B cell antigen epitope as a potential epitope vaccine against Campylobacter jejuni.

Authors:  Hongqiang Lou; Xusheng Li; Fangming Guo; Mingxing Ding; Ye Hu; Haohao Chen; Jie Yan
Journal:  Saudi J Biol Sci       Date:  2019-05-29       Impact factor: 4.219

10.  Recombinant Salmonella Bacteria Vectoring HIV/AIDS Vaccines.

Authors:  Nyasha Chin'ombe; Vurayai Ruhanya
Journal:  Open Virol J       Date:  2013-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.